CytRx Hit With 2nd Investor Suit Over Cancer Drug Trial

By Dani Kass
August 1, 2016, 2:23 PM EDT

Investors in the biopharmaceutical company CytRx Corp. on Friday filed a second potential class action against the company for allegedly concealing the negative effects of a hold the U.S. Food and...

Already a subscriber? Click here to view full article